好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Lifestyle Metrics of Patients with Epilepsy – Dietary Habits, Food Security, Medication Adherence and Seizure Control
Epilepsy/Clinical Neurophysiology (EEG)
P2 - Poster Session 2 (8:00 AM-9:00 AM)
9-001

To evaluate the correlation between dietary habits, food security and seizure control among patients with epilepsy.

Patients with epilepsy may have impaired aspects of psychosocial functioning that may manifest as food insecurity and poor dietary habits, which may be worse among patients with poorly controlled epilepsy.

Validated surveys on dietary habits (Rapid Eating Assessment for Participants Shortened Version – REAP-S) and food security (US Adult Food Security Survey – USAFSS) were given to patients with epilepsy at a tertiary care center supporting an underserved community in the Bronx, NY. These results were correlated with seizure control (well-controlled if last seizure > 1 year ago) and medication adherence (good adherence if rarely misses antiseizure medications). REAP-S scores range from 13 to 39 based on foods consumed (higher scores indicate better diet). USAFSS scores range from 0 to 9 (0 = food secure, higher numbers indicate worse food insecurity).

51 patients (55% female; median age 48, range 21-85; 86% living in the Bronx, NY) completed surveys. Only 33.3% had well-controlled seizures and only 35.3% had good adherence. The median REAP-S score was 27 (estimated national average ~32). 51% of patients were food secure (estimated national average ~86.5%). Food insecure patients had lower median REAP-S score compared to patients who were food secure (25 vs. 29, p=0.017). Patients with poor medication adherence also had worse dietary habits (REAP-S score 26 vs. 29, p=0.014). In the food secure subgroup, there was no significant difference in the proportion of patients with poorly controlled seizures vs. well-controlled (52% vs. 48%, p>0.05). However, in the food insecure subgroup, more patients had poorly controlled seizures (80% vs. 20%, p=0.036).

The patients surveyed scored worse than the estimated national average in terms of dietary habits and food security. Food insecure patients had significantly worse seizure control and diet.
Authors/Disclosures
Gautham V. Upadrasta, MD
PRESENTER
Dr. Upadrasta has nothing to disclose.
Jinyuan Liu, MD (Montefiore Medical Center) Dr. Liu has nothing to disclose.
Sara Lee, MD Dr. Lee has nothing to disclose.
Michelle Ganat, MD (Montefiore Medical Center) Dr. Ganat has nothing to disclose.
Rishi Gupta, MD (Montefiore Medical Center) Dr. Gupta has nothing to disclose.
Seyhmus Aydemir, MD (Montefiore Medical Center) Dr. Aydemir has nothing to disclose.
Jonathan Gursky, MD (Montefiore Medical Center) Dr. Gursky has nothing to disclose.
Sheryl R. Haut, MD (Albert Einstein College of Medicine) Dr. Haut has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Haut has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Haut has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ventus. Dr. Haut has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbieVe. Dr. Haut has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Iqvia.
Saroj D. Kunnakkat, DO (Montefiore Medical Center) Dr. Kunnakkat has nothing to disclose.
Jillian Rosengard, MD (Montefiore Medical Center) Dr. Rosengard has nothing to disclose.
Alexis D. Boro, MD (Montefiore Medical Center / Albert Einstein College of Medicine) Dr. Boro has nothing to disclose.
Daniel Jose Correa, MD, MSc, FAAN (Montefiore Medical Center, Comprehensive Epilepsy Center) Dr. Correa has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. Dr. Correa has or had stock in Aidin Inc.Dr. Correa has received research support from Genentech. Dr. Correa has received research support from Psi Upsilon Foundation Inc.
Victor Ferastraoaru, MD (Montefiore Medical Ctr-Neurology Dept) Dr. Ferastraoaru has nothing to disclose.